BioMed Research International

Effects of Microbiota on Cancer Immune Responses and Immunotherapy


Publishing date
01 Sep 2022
Status
Published
Submission deadline
13 May 2022

Lead Editor

1Guangzhou University, Guangzhou, China

2The Research Institute in Oncology and Hematology, Winnipeg, Canada

3McMaster University, Hamilton, Canada

4Universiti Malaysia Sabah, Kota Kinabalu, Malaysia


Effects of Microbiota on Cancer Immune Responses and Immunotherapy

Description

Microbiota collectively refers to all microorganisms living in a defined environment such as on the skin or in the intestinal tract, mouth, vagina, and eyes, including bacteria, archaea, fungi, and viruses. The largest population of microorganisms in the human body locates in the intestine and is called the gut or intestinal microbiota. Intestinal microbes are involved in a variety of physiological functions to maintain the health of the host, including providing nutrients and vitamins, catabolic drugs, and toxins, protecting the body from pathogens, promoting the development of the immune system, and maintaining epithelial mucosal homeostasis. The microbiota plays an important role in the physiology and pathology of the human body.

Cancer is a leading cause of death in the world. According to the World Health Organization (WHO), 10 million people died from cancer in 2020. It is estimated that 10-20% of cancers can be attributed to microbial infections. Many studies have demonstrated that the intestinal microbiota plays an important role in tumorigenesis. Microbes and their products can either have a direct carcinogenic effect or prevent the occurrence and development of cancer by regulating the production of circulating metabolites, inflammation, and immune responses. Cancer immunotherapy is a very promising therapy by boosting the immune system to kill cancer cells and suppress tumor growth. Microbiota on or in the human body can influence immune responses affecting immunotherapy.

This Special Issue invites original research and review articles which contribute to the understanding of the roles of microbiota in cancer immune responses and immunotherapy which may provide novel approaches in treating cancer.

Potential topics include but are not limited to the following:

  • Research and development of microbe-associated cancer immunotherapy
  • Mechanisms of microbiota disturbance in cancer immune responses
  • Correlation of microbiota with tumorigenesis
  • Screening and application of biomarkers of microbiota in cancer immune responses
  • Mechanisms of bacterial translocation causing cancer
  • Relationship between microbiota and mucosal immunity and its anticancer mechanism
  • Signaling pathways of microbiota regulating tumorigenesis
  • Mechanisms and applications of probiotic bacteria in immunotherapy

Articles

  • Special Issue
  • - Volume 2022
  • - Article ID 9170722
  • - Research Article

[Retracted] Identification of Cigarette Smoking-Related Novel Biomarkers in Lung Adenocarcinoma

Yuan Zhang | Qiong Wang | ... | Hui Chen
  • Special Issue
  • - Volume 2022
  • - Article ID 7132159
  • - Research Article

[Retracted] Brusatol Inhibits Proliferation and Metastasis of Colorectal Cancer by Targeting and Reversing the RhoA/ROCK1 Pathway

Rui-jin Lu | Guo-zhi Zhao | ... | Jing Li
  • Special Issue
  • - Volume 2022
  • - Article ID 9469207
  • - Research Article

[Retracted] Identification of lncRNA Biomarkers and LINC01198 Promotes Progression of Chronic Rhinosinusitis with Nasal Polyps through Sponge miR-6776-5p

Xueping Wang | Xiaoyuan Zhu | ... | Yulin Zhao
  • Special Issue
  • - Volume 2022
  • - Article ID 3113857
  • - Research Article

[Retracted] Discovery of New Therapeutic Targets for Osteosarcoma Treatment Based on Immune-Related lncRNAs in the Tumor Microenvironment

Ribin Fu | Xiaofang Hong
  • Special Issue
  • - Volume 2022
  • - Article ID 2863379
  • - Research Article

[Retracted] Biomechanical Analysis of Different Internal Fixation Combined with Different Bone Grafting for Unstable Thoracolumbar Fractures in the Elderly

Qisong Shang | Yuqing Jiang | ... | Bing Wu
  • Special Issue
  • - Volume 2022
  • - Article ID 4541918
  • - Research Article

[Retracted] Mechanism of RNA circHIPK3 Involved in Resistance of Lung Cancer Cells to Gefitinib

Yi Zhao | Caiming Zhang | ... | Qiugan Qi
  • Special Issue
  • - Volume 2022
  • - Article ID 4404406
  • - Research Article

[Retracted] Development of a 5-Gene Signature to Evaluate Lung Adenocarcinoma Prognosis Based on the Features of Cancer Stem Cells

Renping Wan | Hongliang Liao | ... | Jie Wei
  • Special Issue
  • - Volume 2022
  • - Article ID 8636527
  • - Research Article

[Retracted] Immunotherapy Mechanism of Esophageal Squamous Cell Carcinoma with the Effect of STK11/AMPK Signaling Pathway

Yang Xia | Peng Wang | ... | Gaohua Han
  • Special Issue
  • - Volume 2022
  • - Article ID 3620232
  • - Research Article

Correlation between Vaginal Microecological Status and Prognosis of CIN Patients with High-Risk HPV Infection

Huizhen Zhang | Shuangling Jin | ... | Shujing Shi
  • Special Issue
  • - Volume 2022
  • - Article ID 2897338
  • - Research Article

[Retracted] Effect of FLOT2 Gene Expression on Invasion and Metastasis of Colorectal Cancer and Its Molecular Mechanism under Nanotechnology and RNA Interference

Chonghan Zhong | Fangfang Zheng | ... | Dongning Liu
BioMed Research International
 Journal metrics
See full report
Acceptance rate8%
Submission to final decision128 days
Acceptance to publication21 days
CiteScore5.300
Journal Citation Indicator-
Impact Factor-
 Submit Evaluate your manuscript with the free Manuscript Language Checker

We have begun to integrate the 200+ Hindawi journals into Wiley’s journal portfolio. You can find out more about how this benefits our journal communities on our FAQ.